Condition

Metastatic Castration-Resistant Prostate Carcinoma

ClinicalTrials.gov condition label

Clinical trials9
Recruiting4
Common interventions25
Lead sponsors shown5

Clinical trials

9 shown
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL TrialNCT07200830 · 2026-03-31
RECRUITING
Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing DiseaseNCT06526299 · 2025-04-29
RECRUITING
SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) TherapyNCT07096999 · 2025-01-23
RECRUITING
Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate CancerNCT06236139 · 2024-11-26
RECRUITING
Escalating Cycle 1 Dose of Lu-177-PSMA-617 for the Treatment of Metastatic Castration Resistant Prostate CancerNCT07682649 · 2026-08-01
NOT_YET_RECRUITING
Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP StudyNCT05960578 · 2024-05-23
ACTIVE_NOT_RECRUITING
Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate CancerNCT05828082 · 2023-10-16
ACTIVE_NOT_RECRUITING
An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate CancerNCT04777071 · 2021-05-17
ACTIVE_NOT_RECRUITING
Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal TherapyNCT04071236 · 2020-10-14
ACTIVE_NOT_RECRUITING

Common interventions

Computed TomographyPROCEDURE8Biospecimen CollectionPROCEDURE7Bone ScanPROCEDURE6Magnetic Resonance ImagingPROCEDURE6Questionnaire AdministrationOTHER4Lutetium Lu 177 Vipivotide TetraxetanDRUG3Positron Emission TomographyPROCEDURE3Biopsy ProcedurePROCEDURE2PSMA PET ScanPROCEDURE2Anti-STEAP1 CAR T-cellsBIOLOGICAL1ApalutamideDRUG1AvelumabDRUG1BiopsyPROCEDURE1CyclophosphamideDRUG1Echocardiography TestPROCEDURE1Electronic Health Record ReviewOTHER1EnzalutamideDRUG1FludarabineDRUG1Gallium Ga 68 GozetotideDRUG1Gallium Ga 68 GozetotideOTHER1GolimumabDRUG1LeukapheresisPROCEDURE1MRIPROCEDURE1Multigated Acquisition ScanPROCEDURE1Non-Interventional StudyOTHER1

Trial status mix

ACTIVE_NOT_RECRUITING4
RECRUITING4
NOT_YET_RECRUITING1

Phase mix

PHASE26
PHASE13
PHASE31

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.